3Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type Ⅰ with hepatocyte transplantation. N Engl J Med,1998,338: 1422-1426.
4Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the CriglerNajjar syndrome type I with hepatocyte transplantation. N Engl J Med,1998,338:1422-1426.
1Rhim JA, Sandgren EP, Palmiter RD, et al. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA, 1995, 92: 4942-4946.
2Petersen J, Dandri M, Gupta S, et al. Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci USA, 1998, 95: 310-315.
3Grompe M. Mouse liver goes human: a new tool in experimental hepatology. Hepatology, 2001, 33: 1005-1006.
4Ilan E, Burakova T, Dagan S, et al. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology, 1999, 29: 553-562.
5Ohashi K, Marion PL, Nakai H, et al. Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat Med, 2000, 6: 327-331.
6Dandri M, Burda MR, Torok E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology, 2001, 33: 981-988.
7Watanabe FD, Mullon CJ, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg, 1997, 225: 484-491.
8Sussman NL, Gislason GT, Kelly JH. Extracorporeal liver support.application to fulminaot hepatic failure. J Clin Gastroenterol, 1994,18: 320-324.
9Gerlach JC, Lemmens P, Schon M, et al. Experimental evaluation of a hybrid liver support system. Transplant Proc, 1997, 29: 852.
10Demetriou AA, Rozga J, Podesta L, et al. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol, 1995, 208:111-117.
